69
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Ifosfamide, Epirubicin and Etoposide (IEV) Regimen as Salvage and Mobilization Therapy for Refractory or Early Relapsing Patients with Aggressive Non-Hodgkin's Lymphoma

, , , , , , , , & show all
Pages 1605-1609 | Received 25 Feb 2004, Published online: 26 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

B Li, B Li, Jl Yang, B Li, Jl Yang, Yk Shi, Xh He, Xh Han, Sy Zhou, P Liu, S Yang & Cg Zhang. (2009) Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity. Cytotherapy 11:3, pages 362-371.
Read now
Helge Menzel, Andrea Müller, Christoph Von Schilling, Thomas Licht, Christian Peschel & Ulrich Keller. (2008) Ifosfamide, epirubicin and etoposide rituximab in refractory or relapsed B-cell lymphoma: Analysis of remission induction and stem cell mobilization. Leukemia & Lymphoma 49:7, pages 1337-1344.
Read now
Jing Zhang, Quan Tian, Sui Yung Chan, Shu Chuen Li, Shufeng Zhou, Wei Duan & Yi-Zhun Zhu. (2005) Metabolism and Transport of Oxazaphosphorines and the Clinical Implications. Drug Metabolism Reviews 37:4, pages 611-703.
Read now

Articles from other publishers (12)

Marwah Albakri, Hammad Tashkandi & Lan Zhou. (2020) A Review of Advances in Hematopoietic Stem Cell Mobilization and the Potential Role of Notch2 Blockade. Cell Transplantation 29, pages 096368972094714.
Crossref
Diane M. Calinski, Haoming Zhang, Susan Ludeman, M. Eileen Dolan & Paul F. Hollenberg. (2015) Hydroxylation and N- Dechloroethylation of Ifosfamide and Deuterated Ifosfamide by the Human Cytochrome P450s and Their Commonly Occurring Polymorphisms . Drug Metabolism and Disposition 43:7, pages 1084-1090.
Crossref
Rusudan K. Hopman & John F. DiPersio. (2014) Advances in stem cell mobilization. Blood Reviews 28:1, pages 31-40.
Crossref
Morie A. Gertz. (2010) review: Current status of stem cell mobilization. British Journal of Haematology 150:6, pages 647-662.
Crossref
F. Merli, Roberto Ravasio, I. Alvarez De Cielis & F. Polcaro. (2013) Analisi di costo-efficacia di rituximab più CHOP versus ProMACE-CytaBOM nel trattamento del linfoma diffuso a grandi cellule B: l’esperienza di Reggio Emilia. Giornale Italiano di Health Technology Assessment 2:2, pages 55-64.
Crossref
Susana Vives, Juan-Manuel Sancho, Jordi Juncà, Joan-Ramon Grifols, Mireia Morgades & Josep-Maria Ribera. (2008) Tratamiento de rescate y movilización de progenitores hematopoyéticos de sangre periférica con altas dosis de ifosfamida y etopósido en pacientes con linfoma. Medicina Clínica 130:5, pages 172-174.
Crossref
Robert Ravasio on behalf of the authors. (2008) The Authors?? Reply. Clinical Drug Investigation 28:7, pages 462-463.
Crossref
Felicetto Ferrara & Roberto Ravasio. (2008) Cost-Effectiveness Analysis of the??Addition of Rituximab to CHOP??in Young Patients with Good-Prognosis Diffuse Large-B-Cell Lymphoma. Clinical Drug Investigation 28:1, pages 55-65.
Crossref
Jochen Grassinger, Gunnar Mueller, Christina Hart, Susie K. Nilsson, David N. Haylock, Reinhard Andreesen & Burkhard Hennemann. (2007) Detection and quantification of functionally defined hematopoietic progenitor cells and tissue specific mRNA within the peripheral blood of myeloma patients after administration of granulocyte colony-stimulating factor and erythropoietin. European Journal of Haematology 0:0, pages 071119202650003-???.
Crossref
Christina Hart, Christian Blank, Stefan W. Krause, Reinhard Andreesen & Burkhard Hennemann. (2007) Ifosfamide, epirubicin, and etoposide (IEV) mobilize peripheral blood stem cells more efficiently than cyclophosphamide/etoposide. Annals of Hematology 86:8, pages 575-581.
Crossref
Felicetto Ferrara, Assunta Viola, Carolina Copia, Ettore Mariano Schiavone, Maria Celentano, Filiberto Pollio, Maria Rosaria D'Amico & Salvatore Palmieri. (2006) Therapeutic results in patients with relapsed diffuse large B cell Non‐Hodgkin's lymphoma achieving complete response only after autologous stem cell transplantation. Hematological Oncology 24:2, pages 73-77.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 22:3, pages 135-142.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.